VeriChip Corporation provides radio frequency identification (RFID) systems
for healthcare and patient-related needs in the United States. It offers the
VeriMed Health Link system that uses an implantable passive RFID microchip,
which is used in patient identification applications. The company also
focuses on the development of the glucose-sensing microchip. It has a
strategic partnership with Diabetes Research Institute for the development
of the glucose-sensing radio frequency identification microchip. VeriChip
Corporation was founded in 2001 and is headquartered in Delray Beach,
Florida.